These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23397147)

  • 21. Differential synovial tissue expression of TLRs in seropositive and seronegative rheumatoid arthritis: A preliminary report.
    Abdelwahab A; Palosaari S; Abdelwahab SA; Rifaai RA; El-Tahawy NF; Saber EA; Nousiainen T; Valkealahti M; Huhtakangas J; Karttunen TJ; Lehenkari P
    Autoimmunity; 2021 Feb; 54(1):23-34. PubMed ID: 33377396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
    van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
    Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fcgamma receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs.
    Wijngaarden S; van Roon JA; Bijlsma JW; van de Winkel JG; Lafeber FP
    Rheumatology (Oxford); 2003 May; 42(5):681-8. PubMed ID: 12709546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying markers of sustained remission in rheumatoid arthritis patients on long-term tapered biological disease-modifying antirheumatic drugs.
    Valor L; Garrido J; Martínez-Estupiñán L; Hernández-Flórez D; Janta I; López-Longo FJ; Monteagudo I; González CM; Naredo E
    Rheumatol Int; 2018 Aug; 38(8):1465-1470. PubMed ID: 29915991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis factor blocking therapy alters joint inflammation and hypoxia.
    Kennedy A; Ng CT; Chang TC; Biniecka M; O'Sullivan JN; Heffernan E; Fearon U; Veale DJ
    Arthritis Rheum; 2011 Apr; 63(4):923-32. PubMed ID: 21225682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Midterm clinico-radiologic findings of an open label observation study of add-on tacrolimus with biologics or non-biologic DMARDs.
    Takakubo Y; Tamaki Y; Hirayama T; Iwazaki K; Yang S; Sasaki A; Nakano H; Konttinen YT; Takagi M
    Rheumatol Int; 2012 Nov; 32(11):3487-94. PubMed ID: 22065071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycoprotein 96 perpetuates the persistent inflammation of rheumatoid arthritis.
    Huang QQ; Koessler RE; Birkett R; Dorfleutner A; Perlman H; Haines GK; Stehlik C; Nicchitta CV; Pope RM
    Arthritis Rheum; 2012 Nov; 64(11):3638-48. PubMed ID: 22777994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
    Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
    Front Immunol; 2018; 9():2228. PubMed ID: 30319663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear Factor-κB-inducing Kinase Is Expressed in Synovial Endothelial Cells in Patients with Early Arthritis and Correlates with Markers of Inflammation: A Prospective Cohort Study.
    Maijer KI; Noort AR; de Hair MJ; van der Leij C; van Zoest KP; Choi IY; Gerlag DM; Maas M; Tak PP; Tas SW
    J Rheumatol; 2015 Sep; 42(9):1573-81. PubMed ID: 26178280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generalized estimating equation model to compare drug effects on synovitis of the dominant wrist in severe rheumatoid arthritis between tocilizumab versus adalimumab versus abatacept using high-resolution ultrasound.
    Chen YC; Chiu WC; Su FM; Chen JF
    Int J Rheum Dis; 2018 Sep; 21(9):1695-1700. PubMed ID: 29024421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
    Katschke KJ; Rottman JB; Ruth JH; Qin S; Wu L; LaRosa G; Ponath P; Park CC; Pope RM; Koch AE
    Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synovial activation in rheumatoid arthritis.
    Ospelt C; Neidhart M; Gay RE; Gay S
    Front Biosci; 2004 Sep; 9():2323-34. PubMed ID: 15353290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands.
    Pierer M; Rethage J; Seibl R; Lauener R; Brentano F; Wagner U; Hantzschel H; Michel BA; Gay RE; Gay S; Kyburz D
    J Immunol; 2004 Jan; 172(2):1256-65. PubMed ID: 14707104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.
    Humby F; Lewis M; Ramamoorthi N; Hackney JA; Barnes MR; Bombardieri M; Setiadi AF; Kelly S; Bene F; DiCicco M; Riahi S; Rocher V; Ng N; Lazarou I; Hands R; van der Heijde D; Landewé RBM; van der Helm-van Mil A; Cauli A; McInnes I; Buckley CD; Choy EH; Taylor PC; Townsend MJ; Pitzalis C
    Ann Rheum Dis; 2019 Jun; 78(6):761-772. PubMed ID: 30878974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission.
    Ramírez J; Celis R; Usategui A; Ruiz-Esquide V; Faré R; Cuervo A; Sanmartí R; Pablos JL; Cañete JD
    Arthritis Res Ther; 2016 Mar; 18():74. PubMed ID: 27036513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a Novel Toll-like Receptor 7 Endogenous Ligand in Rheumatoid Arthritis Synovial Fluid That Can Provoke Arthritic Joint Inflammation.
    Kim SJ; Chen Z; Essani AB; Elshabrawy HA; Volin MV; Volkov S; Swedler W; Arami S; Sweiss N; Shahrara S
    Arthritis Rheumatol; 2016 May; 68(5):1099-110. PubMed ID: 26662519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of innate immune sensors, TLRs, and NALP3 in rheumatoid arthritis and osteoarthritis.
    Takakubo Y; Barreto G; Konttinen YT; Oki H; Takagi M
    J Long Term Eff Med Implants; 2014; 24(4):243-51. PubMed ID: 25747027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.